Semenova Y 2
51. Prevalence of Smoking Various Tobacco Types in the Kazakhstani Adult Population in 2021: A Cross-Sectional Study
52. Epidemiological Characteristics and Maternal Risk Factors of Microtia and Aural Atresia in Kazakhstan
53. Abnormal Porphyrin Metabolism in Autism Spectrum Disorder and Therapeutic Implications
54. Factors Influencing Antibiotic Consumption in Adult Population of Kazakhstan
55. Association between serum 25-hydroxyvitamin D concentration and severity of seasonal allergic rhinitis in Karaganda region (Kazakhstan)
56. Molecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis
57. Past, current status, and future trends of the rural healthcare network in the Republic of Kazakhstan
58. The impact of incentive scheme on rural healthcare workforce availability: a case study of Kazakhstan
59. Antimicrobial Effect of Honey Phenolic Compounds against E. coli—An In Vitro Study
60. National trends in Azithromycin consumption during 2017–2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines
61. Pressure Ulcers and Nutrients: From Established Evidence to Gaps in Knowledge
62. Worldwide Prevalence of Alcohol Use in Non-Fatally Injured Motor Vehicle Drivers: A Systematic Review and Meta-Analysis
63. The Roles of Endogenous D2R Dopamine and μ-opioid Receptors of the Brain in Alcohol use Disorder
64. The Implementation of Antimicrobial Consumption Surveillance and Stewardship in Human Healthcare in Post-Soviet States: A Systematic Review
65. Osteoporosis: Relevance of Biomolecules for Diagnosis and Treatment
66. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients
67. Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients
68. Impact of Social Determinants of Health on the Incidence of Tuberculosis in Central Asia
69. Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control
70. Optimizing antibiotic stewardship and reducing antimicrobial resistance in Central Asia: A study protocol for evidence-based practice and policy
71. Public Health Communication Challenges in Eastern Europe and Central Asia: A Scoping Review
72. The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level
73. Evaluation of Branched-Chain Amino Acids in Children with Autism Spectrum Disorder and Epilepsy
74. Gamma-aminobutyric acid and glutamate system dysregulation in a small population of Egyptian children with autism spectrum disorder
75. Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017
76. Characteristics of the Online Market for Anabolic-Androgenic Steroids in Central Asia: A Netnographic Analysis
77. Comparative analysis of triage systems at emergency departments of different countries: Implementation in Kazakhstan
78. Cryptogenic Stroke and Embolic Stroke of Undetermined Source: Risk Factors and Approaches for Detection of Atrial Fibrillation
79. Epidemiology of tuberculosis in Kazakhstan: data from the Unified National Electronic Healthcare System 2014-2019
80. The Worldwide Prevalence of Internet Addiction among Medical Students: A Systematic Review and Meta-Analysis
81. Cross-cultural adaptation and validation of patient safety culture assessment tool for clinical staff in Kazakhstan
82. Detection of the Frail Elderly at Risk of Postoperative Sepsis
83. A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
84. Antimicrobial Resistance and the Blood–Brain Barrier: Complex Interactions and Implications for Neurological Health
85. Antioxidants and neurodegenerative eye disease
86. Associations between medical education reforms and trends in the ophthalmology workforce and cataract surgery performance in Kazakhstan
87. Chemotherapy Options for Locally Advanced Gastric Cancer: A Review
88. Consumption Trends of Antifungal and Antiprotozoal Agents for Human Systemic Use in Kazakhstan from 2017 to 2023
89. Epidemiology of stroke and transient ischemic attacks in the population of the territories adjacent to the former Semipalatinsk Nuclear Test Site, Kazakhstan
90. Evaluation of liver transplantation services in Kazakhstan from 2012 to 2023
91. Examining a 12-year experience within Kazakhstan’s national heart transplantation program
92. Historical evolution of healthcare systems of post-soviet Russia, Belarus, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Armenia, and Azerbaijan: A scoping review
93. Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders
94. Knowledge, Attitudes, and Practices towards Antibiotics, Antimicrobial Resistance, and Antibiotic Consumption in the Population of Kazakhstan
95. Point-Prevalence Survey of Antimicrobial Use and Healthcare-Associated Infections in Four Acute Care Hospitals in Kazakhstan
96. Refractive Errors, Amplitude of Accommodation, and Myopia Progression in Kazakhstani Medical Students: 5-Year Follow-Up
97. Seropositivity of SARS-CoV-2 in the Population of Kazakhstan: A Nationwide Laboratory-Based Surveillance
98. Social Determinants of Health and Antibiotic Consumption
99. Systemic antiviral consumption in Kazakhstan
100. Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques
1 2 3